192 related articles for article (PubMed ID: 1360937)
1. Conservative treatment of acute pancreatitis: the use of somatostatin.
Ladas SD; Raptis SA
Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
[TBL] [Abstract][Full Text] [Related]
2. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
Greenberg R; Haddad R; Kashtan H; Kaplan O
J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
[TBL] [Abstract][Full Text] [Related]
4. Therapy of acute pancreatitis with somatostatin.
Raptis SA; Ladas SD
Scand J Gastroenterol Suppl; 1994; 207():34-8. PubMed ID: 7701265
[TBL] [Abstract][Full Text] [Related]
5. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
[TBL] [Abstract][Full Text] [Related]
6. [Somatostatin in the treatment of pancreatic diseases].
Németh AM
Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
8. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
[TBL] [Abstract][Full Text] [Related]
9. Effects of delayed administration of octreotide in acute experimental pancreatitis.
Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y
J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496
[TBL] [Abstract][Full Text] [Related]
10. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
[TBL] [Abstract][Full Text] [Related]
11. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
[TBL] [Abstract][Full Text] [Related]
12. The role of octreotide and somatostatin in acute and chronic pancreatitis.
Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on the therapeutic effects of SMS201-995 on bile-induced acute pancreatitis in the dog].
Satoh M
Hokkaido Igaku Zasshi; 1998 Jan; 73(1):37-46. PubMed ID: 9546145
[TBL] [Abstract][Full Text] [Related]
14. Potential role of somatostatin and octreotide in the management of acute pancreatitis.
Büchler MW; Binder M; Friess H; Malfertheiner P
Digestion; 1994; 55 Suppl 1():16-9. PubMed ID: 7907565
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin and octreotide in the management of acute variceal hemorrhage.
Avgerinos A; Armonis A; Raptis S
Hepatogastroenterology; 1995 Apr; 42(2):145-50. PubMed ID: 7672763
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
Masclee AA; Jansen JB; Lamers CB
Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
[No Abstract] [Full Text] [Related]
17. [Effect of somatostatin analogue on experimental pancreatic lesions and their sequelae].
Tulassay Z; Németh J; Varga G; Papp M
Orv Hetil; 1991 Jul; 132(30):1631-8. PubMed ID: 1866157
[TBL] [Abstract][Full Text] [Related]
18. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.
Büchler MW; Binder M; Friess H
Gut; 1994; 35(3 Suppl):S15-9. PubMed ID: 7911442
[TBL] [Abstract][Full Text] [Related]
19. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
Delmont J; Hastier P; Dumas R
Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
[No Abstract] [Full Text] [Related]
20. Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?
McKay CJ; Imrie CW; Baxter JN
Gut; 1993 Nov; 34(11):1622-6. PubMed ID: 7902312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
